← Leaderboards
Anna I Dongari-Bagtzoglou
Columbia University Health Sciences
$11,106,244
Attributed
$14,757,179
Total exposure
14
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,757,179 · 14
By mechanism
R01$13,235,035 · 3
R21$1,291,305 · 3
M01$145,589 · 7
R03$85,250 · 1
Top collaborators
- Reinhard Laubenbacher5 shared
- Pedro Mendes5 shared
- Patricia Diaz4 shared
- Douglas Edward Peterson4 shared
- Linda D Strausbaugh4 shared
- Carol A. Kumamoto1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David H Sachs$52,326,282
Others in their field
Top investigators on “Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$236,409,338
- Judith S. Currier · University Of California Los Angeles$134,347,732
- Constance Ann Benson · University Of California, San Diego$123,741,444
- Wafaa M. El-Sadr · Columbia University Health Sciences$92,413,650
- Myron S Cohen · Family Health International$91,263,426
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
OralCandidaNeutrophilOral Mucous Membrane StructureImmunocompromised HostMucous MembraneInfectionEnvironmentCandida AlbicansEpithelial CellsResponsePathogenesisOrganismCandidiasisOral CandidiasisComplexMicrobial BiofilmsPathogenMicrobialMycosesGrantImmune ResponseImmune SystemCells
Grant awards (45)
Pathogenicity of ethanol tolerant strains of Candida albicans in the oral cavity$463,530
R21 · FY2025 · DE
Oral Epithelial Cells, Candida and PMN Activation$507,193
R01 · FY2024 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$585,220
R01 · FY2023 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$564,656
R01 · FY2022 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$576,344
R01 · FY2021 · DE · contact PI
Control of heterogeneous microbial communities using model-based multi-objective optimization$421,753
R01 · FY2021 · GM
Oral Epithelial Cells, Candida and PMN Activation$576,344
R01 · FY2020 · DE · contact PI
Control of heterogeneous microbial communities using model-based multi-objective optimization$421,753
R01 · FY2020 · GM
Control of heterogeneous microbial communities using model-based multi-objective optimization$421,753
R01 · FY2019 · GM
Control of heterogeneous microbial communities using model-based multi-objective optimization$431,323
R01 · FY2018 · GM
Oral Epithelial Cells, Candida and PMN Activation$398,750
R01 · FY2018 · DE · contact PI
Control of heterogeneous microbial communities using model-based multi-objective optimization$110,182
R01 · FY2018 · GM
Oral Epithelial Cells, Candida and PMN Activation$398,750
R01 · FY2017 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$398,750
R01 · FY2016 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$398,583
R01 · FY2015 · DE · contact PI
Model of chemotherapy-induced mucositis$199,375
R21 · FY2015 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$412,250
R01 · FY2014 · DE · contact PI
Model of chemotherapy-induced mucositis$229,650
R21 · FY2014 · DE · contact PI
The oral microbiome during cancer chemotherapy and its role in oral mucositis$756,222
R01 · FY2013 · DE
The oral microbiome during cancer chemotherapy and its role in oral mucositis$803,123
R01 · FY2012 · DE
The oral microbiome during cancer chemotherapy and its role in oral mucositis$715,756
R01 · FY2011 · DE
Oral Epithelial Cells, Candida and PMN Activation$503,652
R01 · FY2011 · DE · contact PI
The oral microbiome during cancer chemotherapy and its role in oral mucositis$677,780
R01 · FY2010 · DE
Oral Epithelial Cells, Candida and PMN Activation$514,782
R01 · FY2010 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$506,848
R01 · FY2009 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$213,438
R01 · FY2009 · DE · contact PI
Oral Epithelial Cells, Candida and PMN Activation$401,595
R01 · FY2008 · DE · contact PI
ORAL CANDIDA$8,260
M01 · FY2008 · RR · contact PI
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS$7,850
M01 · FY2008 · RR · contact PI
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS$28,324
M01 · FY2007 · RR · contact PI
ORAL CANDIDA$9,816
M01 · FY2007 · RR · contact PI
Oral Epithelial Cell Cytokines Candida & PMN Activation$318,584
R01 · FY2006 · DE · contact PI
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS$83,790
M01 · FY2006 · RR · contact PI
Oral Epithelial Cell Cytokines Candida &PMN Activation$290,000
R01 · FY2005 · DE
Oral infection and inflammation in transplant patients$181,250
R21 · FY2005 · DE
ORAL CANDIDA$1,246
M01 · FY2005 · RR
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS$763
M01 · FY2005 · RR
Oral Epithelial Cell Cytokines Candida &PMN Activation$290,000
R01 · FY2004 · DE
Oral infection and inflammation in transplant patients$217,500
R21 · FY2004 · DE
Oral Candida$5,540
M01 · FY2004 · RR
ORAL EPITHELIAL CELL CYTOKINES CANDIDA &PMN ACTIVATION$184,875
R01 · FY2002 · DE
ORAL EPITHELIAL CELL CYTOKINES CANDIDA &PMN ACTIVATION$217,388
R01 · FY2001 · DE
ORAL MUCOSAL CELLS, CANDIDA AND CYTOKINE PRODUCTION$42,625
R03 · FY2001 · DE
ORAL EPITHELIAL CELL CYTOKINES--CANDIDA &PMN ACTIVATION$217,388
R01 · FY2000 · DE
ORAL MUCOSAL CELLS, CANDIDA AND CYTOKINE PRODUCTION$42,625
R03 · FY2000 · DE